Pharmaceutical Policy

Economic Impact Analysis of Stormwater Control Requirements: Model Commercial Building Project [W-02-06-40397]

Closure Model Results: Single-Family Residential [W-02-06-40393]

Lennar Corp: SEC Filings Balance Sheet and Income Statement [W-02-06-40377]

Nonemployer Statistics [W-02-06-40327]

Low Impact Development in Puget Sound [W-02-06-40323]

Table Q-1: New Privately Owned Housing Units Started [W-02-06-40353]

Economic Impact Analysis of Stormwater Control Requirements: Model Multifamily Building Project [W-02-06-40398]

Table FA-10: Obligation of Federal-Aid Highway Funds for Highway Improvements [W-02-06-40359]

Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing

Reference List re: Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing

Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661

Citizen Petition from Solvay Pharmaceuticals